3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Intermediate Factory 98.0%
Matsakaicin Matsakaici Mai alaƙa da Samfuran Argatroban:
Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Sunan Sinadari | 3-Methyl-8-Quinolinesulphonyl Chloride |
Makamantu | 3-Methylquinoline-8-sulfonyl chloride |
Lambar CAS | 74863-82-4 |
Lambar CAT | Saukewa: RF-PI269 |
Matsayin Hannun jari | A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton |
Tsarin kwayoyin halitta | Saukewa: C10H8ClNO2S |
Nauyin Kwayoyin Halitta | 241.69 |
Yawan yawa | 1.4± 0.1 g/cm3 |
Fihirisar Refractive | 1.63 |
Solubility | Mai narkewa a cikin Chloroform |
Yanayin jigilar kaya | An aika Karkashin Zazzabin yanayi |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Farin Crystalline Foda |
Tsarkake / Hanyar Bincike | 98.0% (HPLC) |
Matsayin narkewa | 162.0 ~ 163.0 ℃ |
Asara akan bushewa | <0.50% |
3-Methylquinoline-8-Sulfonic Acid | <1.00% |
Jimlar ƙazanta | <2.00% |
Infrared Spectrum | Yayi daidai da Tsarin |
NMR | Yayi daidai da Tsarin |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Argatroban (CAS 74863-84-6) |
Kunshin: Bottle, Aluminum tsare jakar, 25kg / kwali Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske & danshi
Shanghai Ruifu Chemical Co., Ltd. shine babban masana'anta kuma mai samar da 3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) tare da babban inganci, ana amfani dashi ko'ina a cikin haɓakar ƙwayoyin cuta, haɓakar magunguna na tsaka-tsaki da Matsakaicin Magungunan Magungunan Active Pharmaceutical (API) kira.YanaMatsakaici ne yawanci a cikin haɗin Argatroban (CAS: 74863-84-6) ko Argatroban Monohydrate (CAS 141396-28-3).
Argatroban (CAS: 74863-84-6) maganin rigakafi ne wanda shine ƙaramin ƙwayar ƙwayar ƙwayar cuta kai tsaye mai hana thrombin.A cikin 2000, Cibiyar Abinci da Magunguna (FDA) ta ba da lasisin argatroban don rigakafi ko maganin thrombosis a cikin marasa lafiya tare da thrombocytopenia mai haifar da heparin (HIT).A cikin 2002, an ba da izinin amfani da shi a yayin da ake aiwatar da aikin jijiyoyin jini a cikin marasa lafiya waɗanda ke da HIT ko kuma suna cikin haɗarin haɓaka ta.A cikin 2012, MHRA ta amince da ita a cikin Burtaniya don maganin rigakafi a cikin marasa lafiya tare da heparin-induced thrombocytopenia Type II (HIT) wanda ke buƙatar magungunan antithrombotic parenteral.